While the science behind KPV is compelling, theres still so much we dont know about the peptide and how it impacts humans
You can also associate side effects with meals, hydration or activity levels, making it easier to spot patterns and have informed conversations with your healthcare provider
Anandacoomarasamy A, Caterson I, Sambrook P, Fransen M, March L
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
One small study published in 2017 found the same result, though much more research is needed
More broadly, changes in willingness to pay among GLP-1 users are likely to influence nationwide prices as markets adjust to the rising adoption of this treatment